Literature DB >> 17522920

Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial.

P Miccoli1, P Berti, G Materazzi, C E Ambrosini, L Fregoli, G Donatini.   

Abstract

BACKGROUND: Quick intraoperative parathormone assay (qPTHa) during paratyroidectomy has become a standard procedure for patients with primary hyperparathyroidism (PHPT). This paper aims to compare endoscopic bilateral neck exploration (BE) versus focused parathyroidectomy plus qPTHa during minimally invasive video-assisted parathyroidectomy (QM). The endpoints of the study are the mean operative time and outcome of the surgical procedure (PTH and calcemia normalization at one and six months postoperatively).
METHODS: Forty patients with PHPT, positive to preoperative localization studies (ultrasonography evaluation and (99)Tc-MIBI scan) for a single parathyroid adenoma, were randomly allotted into two groups. In the first group (QM), 20 patients (17 women, three men, mean age 57.6 years) underwent focused endoscopic parathyroidectomy (MIVAP tecnicque) plus qPTHa . In the second group (BE) 20 patients (17 women, three men, mean age 59.6 years) underwent endoscopic parathyroidectomy plus bilateral exploration in order to check the integrity of the remaining glands.
RESULTS: There were no significant differences between groups at baseline. No conversion to cervicotomy was required. No postoperative complications were reported. The mean operative time was 32.0 vs 33.1 min [BE and QM group respectively, p = not significant (ns)]. A second macroscopically enlarged gland was removed in four patients in the BE group. Only one out of four glands was reported to be hyperplastic in the final histology. All patients were discharged on the first postoperative day. Calcemia levels were normalized in all patient of both groups, despite persistently high level of serum PTH in one patient in the QM group.
CONCLUSIONS: BE can be performed endoscopically, avoiding both the time necessary for qPTHa and its cost, with the same effectiveness, but might in few cases lead to the unjustified removal of parathyroid glands slightly enlarged but not necessarily pathologic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522920     DOI: 10.1007/s00464-007-9408-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

1.  Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience.

Authors:  P G Gauger; G Agarwal; B G England; L W Delbridge; K A Matz; M Wilkinson; B G Robinson; N W Thompson
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

2.  Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy.

Authors:  Wendy R Sackett; Bruce Barraclough; Tom S Reeve; Leigh W Delbridge
Journal:  Arch Surg       Date:  2002-09

3.  Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery.

Authors:  I J Phillips; T R Kurzawinski; J W Honour
Journal:  Ann Clin Biochem       Date:  2005-11       Impact factor: 2.057

4.  Minimally invasive videoscopic parathyroidectomy by lateral approach.

Authors:  J F Henry; T Defechereux; L Gramatica; C de Boissezon
Journal:  Langenbecks Arch Surg       Date:  1999-06       Impact factor: 3.445

5.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.

Authors:  Clive S Grant; Geoffrey Thompson; David Farley; Jon van Heerden
Journal:  Arch Surg       Date:  2005-05

6.  Results of video-assisted parathyroidectomy: single institution's six-year experience.

Authors:  Paolo Miccoli; Piero Berti; Gabriele Materazzi; Marco Massi; Antonella Picone; Michele N Minuto
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

7.  Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism.

Authors:  A Bergenfelz; V Kanngiesser; A Zielke; C Nies; M Rothmund
Journal:  Br J Surg       Date:  2005-02       Impact factor: 6.939

8.  Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?

Authors:  Denise M Carneiro; Carmen C Solorzano; Maria C Nader; Marcela Ramirez; George L Irvin
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

9.  Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial.

Authors:  Marcin Barczyński; Stanisław Cichoń; Aleksander Konturek; Wojciech Cichoń
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

10.  Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.

Authors:  J P Wei; G J Burke; A R Mansberger
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

View more
  20 in total

1.  Minimally invasive video-assisted subtotal parathyroidectomy with thymectomy for secondary hyperparathyroidism.

Authors:  Umut Barbaros; Yeşim Erbil; Alaattin Yildirim; Gülay Saricam; Halil Yazici; Selçuk Ozarmağan
Journal:  Langenbecks Arch Surg       Date:  2008-08-23       Impact factor: 3.445

2.  The use of positron emission tomography with (11)C-methionine in patients with primary hyperparathyroidism.

Authors:  Filomena Cetani; Claudio Marcocci
Journal:  Endocrine       Date:  2013-02-03       Impact factor: 3.633

3.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  Current concepts in the management of primary hyperparathyroidism.

Authors:  N Gopalakrishna Iyer; Ashok R Shaha
Journal:  Indian J Surg Oncol       Date:  2010-11-21

5.  Is minimally invasive parathyroidectomy without QPTH monitoring justified?

Authors:  Philipp Riss; Christian Scheuba; Reza Asari; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2009-05-14       Impact factor: 3.445

Review 6.  Video-assisted minimally invasive parathyroidectomy: benefits and long-term results.

Authors:  Celestino P Lombardi; Marco Raffaelli; Emanuela Traini; Carmela De Crea; Salvatore M Corsello; Rocco Bellantone
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

7.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

Review 8.  Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism.

Authors:  Benjamin L Judson; Ashok R Shaha
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

9.  Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).

Authors:  L Rosato; M Raffaelli; R Bellantone; A Pontecorvi; N Avenia; M Boniardi; M L Brandi; F Cetani; M G Chiofalo; G Conzo; M De Palma; G Gasparri; A Giordano; N Innaro; E Leopaldi; G Mariani; C Marcocci; P Marini; P Miccoli; P Nasi; F Pacini; R Paragliola; M R Pelizzo; M Testini; G De Toma
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

10.  Feasibility of video-assisted bilateral neck exploration for patients with primary hyperparathyroidism and failed or discordant localization studies.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Matthias Heuer; Sebastian Hofmeister; Beate Meier; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2012-11-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.